Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bert de Jong"'
Publikováno v:
Veterinary Quarterly, Vol 44, Iss 1, Pp 1-11 (2024)
Hemorrhagic bowel syndrome (HBS) is characterized by a dissecting intramucosal hematoma at the small bowel, causing obstruction and severe hemorrhage in dairy cattle. Recent investigation revealed the presence of early-stage lesions in cows affected
Externí odkaz:
https://doaj.org/article/e25cd9be7f9d4f1c97964b7af910e81c
Autor:
Bert De Jonge, Bart Pardon, Jeroen Dewulf, Evy Goossens, Jasper het Lam, Evert van Garderen, Stefan Roels, Jozefien Callens, Thierry Petitjean, Koen Chiers
Publikováno v:
Animals, Vol 14, Iss 1, p 107 (2023)
Hemorrhagic bowel syndrome (HBS) is a poorly understood, sporadic and often fatal disease in cattle. Although, HBS is considered an important disease in dairy cattle, epidemiological data is largely lacking. This study describes the epidemiology of H
Externí odkaz:
https://doaj.org/article/2bc370461b524008ac1abcaad94c36a5
Autor:
Kiran Alapaty, Ben Allen, Greg Bell, David Benton, Tom Brettin, Shane Canon, Eli Dart, Steve Cotter, Silvia Crivelli, Rich Carlson, Vince Dattoria, Narayan Desai, Richard Egan, Brian Tierney, Ken Goodwin, Susan Gregurick, Susan Hicks, Bill Johnston, Bert de Jong, Kerstin Kleese van Dam, Miron Livny, Victor Markowitz, Jim McGraw, Raymond McCord, Chris Oehmen, Kevin Regimbal, Galen Shipman, Gary Strand, Jeff Flick, Susan Turnbull, Dean Williams, Jason Zurawski
The Energy Sciences Network (ESnet) is the primary provider of network connectivity for the U.S. Department of Energy (DOE) Office of Science (SC), the single largest supporter of basic research in the physical sciences in the United States. To suppo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c52143b6151fd80e8d606d77950dadf
https://doi.org/10.2172/1000971
https://doi.org/10.2172/1000971
Publikováno v:
Chest. 111
Pranlukast (SB 205312, ONO-1078) is an orally active, potent, selective blocker of peptidyl-leukotriene receptors. Pranlukast has been studied in a worldwide clinical development program and recently was approved in Japan for the treatment of asthma.